Today: 9 June 2026
HKEX stock ends 2025 slightly lower as Hong Kong IPO rush sets up 2026 catalysts
1 January 2026
2 mins read

HKEX stock ends 2025 slightly lower as Hong Kong IPO rush sets up 2026 catalysts

NEW YORK, January 1, 2026, 08:33 ET — Market closed

  • HKEX (0388.HK) last closed down 0.24% at HK$407.60 on Dec. 31.
  • A late-December wave of Chinese IPO launches kept the listings outlook in focus heading into 2026.
  • Investors are watching early-January debuts and HKEX’s Feb. 26 annual results for signs the rebound has legs.

Shares of Hong Kong Exchanges and Clearing Ltd (0388.HK) slipped 0.24% to HK$407.60 on Wednesday, as investors weighed a year-end rush of Chinese IPO launches and broader China-linked risk appetite. Hong Kong markets are shut on Jan. 1 for the New Year holiday and reopen on Jan. 2.

For HKEX, the operator of the city’s stock exchange, activity is the product. More IPOs and higher turnover — the total value of shares traded — generally translate into higher fee income, while quieter markets tend to crimp revenue.

That linkage is back in focus after a late-December burst of Hong Kong flotation activity from Chinese AI and semiconductor firms. Chinese AI firm MiniMax is targeting up to HK$4.19 billion ($539 million) ahead of a Jan. 9 debut, and Hong Kong raised $36.5 billion from 114 listings in 2025, more than triple 2024 levels, LSEG data show. “The wave of IPO approvals does suggest a shift in accelerating AI startup development through capital market access,” said Lian Jye Su, chief analyst at tech research firm Omdia. Reuters

Six Chinese companies debuted in Hong Kong on Tuesday after raising about HK$6.99 billion ($900 million), with most trading above their offer prices, Reuters reported. The pipeline also includes three more deals slated to list on Jan. 8, according to the report.

Macro signals out of China also landed as investors headed into the holiday break. China’s official manufacturing Purchasing Managers’ Index (PMI) — a survey gauge of factory conditions where readings above 50 indicate expansion — rose to 50.1 in December from 49.2 in November, returning to growth territory, Reuters reported.

At a New Year gathering with senior officials, Chinese President Xi Jinping said China was on track to meet its 2025 growth target of around 5% and promised more proactive macroeconomic policies in 2026, Reuters reported. The remarks fed into bets that policymakers will lean against weakness in domestic demand and the property downturn.

In Hong Kong, the Hang Seng Index ended Wednesday down 0.87% at 25,630.54, keeping a lid on risk-taking into the final hours of the year.

HKEX shares have risen about 42% over the past 52 weeks, but they remain below a 52-week high of HK$466, according to Yahoo Finance data. The stock’s 50-day moving average — the average closing price over the last 50 sessions — sits around HK$416.77.

On Wednesday, the shares traded between HK$405.80 and HK$409.80, with about 1.55 million shares changing hands, Yahoo Finance data show. Thin year-end volumes can magnify small swings, particularly in financial stocks tied to market activity.

Investors are now testing whether Hong Kong’s reopening in listings is a durable trend or a year-end sprint. They are also watching flows through Stock Connect, the cross-border trading link that allows mainland and Hong Kong investors to buy eligible shares in each other’s markets.

Before the next session, traders will look for a quick rebound in cash-market turnover after the holiday and for signs that new listings can clear at the top of indicated ranges. A steady first week would help HKEX, whose earnings are geared to market activity more than direction.

HKEX’s next major catalyst is its 2025 annual results, due for board approval on Feb. 26, when directors will also consider a dividend, a filing showed.

In that report, investors will focus on whether the listing rebound is flowing through to fee income and whether management flags any changes in the pace of new applications. Expenses and any commentary on technology and regulatory costs will matter alongside the dividend decision.

Stock Market Today

  • Uranium Energy Shares Fall 17% on Larger Q3 Loss Despite New Production Start
    June 9, 2026, 4:11 PM EDT. Uranium Energy Corp shares fell 17% to $10.43 after reporting a fiscal third-quarter net loss of $52.3 million, up from $30.2 million a year earlier. The Texas-based uranium miner began production at its Burke Hollow project, using in-situ recovery (ISR), which extracts uranium by dissolving ore underground. The company ended the quarter with $794 million in liquid assets and no debt. Weak sales of purchased uranium inventory contributed to the loss, dropping gross profit from sales to $10 million from $24.5 million last year. CEO Amir Adnani highlighted ongoing challenges in uranium conversion, a key step for nuclear fuel production. Despite falling shares, UEC expects production to rise in the fourth quarter as new facilities at Burke Hollow and Christensen Ranch operate fully. Market uranium prices remained stable near $85.70 per pound.

Latest articles

Wall Street on Edge as Nasdaq AI Losses Deepen Before CPI, IPOs

Wall Street on Edge as Nasdaq AI Losses Deepen Before CPI, IPOs

9 June 2026
Nasdaq plunged 1.21% and S&P 500 fell 0.53% as tech and AI stocks resumed their sharp selloff, with the S&P tech index down over 4% at one point, while investors braced for Wednesday’s key CPI inflation data, Iran risks, and a wave of major IPOs that could force further stock rotation.
Dow Edges Up 16 Points, Nasdaq Falls After Bell

Dow Edges Up 16 Points, Nasdaq Falls After Bell

9 June 2026
Tech stocks plunged, dragging the Nasdaq down 1.21% as investors dumped AI and chip shares ahead of key inflation data and after President Trump called for a U.S. response to Iran’s downing of a U.S. helicopter; the Dow edged up just 16 points as volatility spiked to its highest since April 7.
POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

9 June 2026
POET Technologies plunged 13% to $10.65 as renewed class-action reminders and April’s Marvell/Celestial AI order cancellation kept legal and execution risks in focus, outweighing a $50 million Lumilens order and $400 million financing, while broader AI chip stocks also slumped.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop